Daily non-political popular news in brief.

Study found no drug interference with pomegranate juice

A study published in the Journal of Clinical Pharmacology finds that pomegranate juice does not interact with medication. Earlier studies suggested that, like grapefruit juice, pomegranate juice may interfere with metabolism of drugs by inhibiting CYP3A, an enzyme that allows the body to transform and eliminate a drug. This is the first study using human subjects to test the drug interactions of pomegranate juice, unlike prior studies which were conducted in vitro and in animals.

Read more »

Keywords: study, drug, interference, pomegranate, juice

« Previous | Next »

Similar news on "Study found no drug interference with pomegranate juice":

1. POM Wonderful 100% Pomegranate Juice may improve erectile dysfunction
   07-02-2007 · EurekAlert!
   According to a pilot study released in the International Journal of Impotence Research, drinking 8 ounces of POM Wonderful 100% Pomegranate Juice daily was found to have beneficial effects on erectile dysfunction, a disorder that affects one in 10 men worldwide. Compared to participants taking a placebo, men with mild to moderate ED who drank POM Wonderful Pomegranate Juice for four weeks were 50 percent more likely to experience a benefit.
   Similar news · Read more »
   
2. Women may be able to 'take break' from osteoporosis drug without losing benefit
   12-26-2006 · EurekAlert!
   Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect, according to a study in the December 27 issue of JAMA.
   Similar news · Read more »
   
3. Cetuximab may prolong survival for head and neck cancer patients
   01-18-2007 · EurekAlert!
   Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
   Similar news · Read more »
   
4. Proteochemometrics achieves better retardants for HIV/Aids
   03-14-2007 · EurekAlert!
   A new method for analysis of retroviral proteins gives new opportunities to the development of novel retardants for HIV/Aids. The study, which was published in the March issue of PLoS Computational Biology, shows how to in a very exact way analyze the interaction of drug targets with small molecules.
   Similar news · Read more »
   
5. Drug-eluting and bare-metal stents equal in risk of blood clots, heart attacks and death
   03-24-2007 · EurekAlert!
   Although the use of stents to treat coronary artery disease has soared during the past decade thanks to novel equipment and new implant techniques, clinical data has recently raised concerns around the safety of drug-eluting stents (DES) and their risk of post-procedure complications. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit compared rates of complications in thousands of patients who received bare-metal stents (BMS) or DES.
   Similar news · Read more »
   
6. Study suggests some drug resistance to influenza B medications
   04-03-2007 · EurekAlert!
   Use of certain common antiviral drugs during a recent influenza B epidemic in Japan showed the development of viruses with partial resistance to the drugs, according to a study in the April 4 issue of JAMA.
   Similar news · Read more »
   
7. Study finds drug helps PTSD nightmares
   04-11-2007 · EurekAlert!
   A generic drug already used by millions of Americans for high blood pressure and prostate problems has been found to improve sleep and lessen trauma nightmares in veterans with posttraumatic stress disorder (PTSD).
   Similar news · Read more »
   
8. TXNIP -- Regulator of glucose homeostasis and potential diabetes drug target and more
   04-30-2007 · EurekAlert!
   Glucose homeostasis, the appropriate balancing of blood sugar levels, is impaired early in patients who become diabetic, causing life-threatening complications such as kidney failure and heart attacks. A study of the mechanisms of glucose homeostasis and early diabetes has dentified a key regulator of glucose homeostasis in humans.
   Similar news · Read more »
   
9. Drugs users are increasingly more cautious with needles
   05-14-2007 · EurekAlert!
   Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.
   Similar news · Read more »
   
10. New designer lipid-like peptide with lipid nanostructures for drug delivery systems
    05-29-2007 · EurekAlert!
    Scientists from Institute of Biophysics and Nanosystems Research (IBN), Austrian Academy of Sciences and of Centre for Biomedical Engineering, Massachusetts Institute of Technology, Cambridge, USA report the study of "Tuning Curvature and Stability of Monoolein Bilayers by Designer Lipid-Like Peptide Surfactants" in the May 30th issue of the online, open-access journal PLoS ONE.
    Similar news · Read more »